Efficacy and safety of CDP-choline, cerebrolysin, MLC601, and edaravone in recovery of patients with acute ischemic strokes: a meta-analysis

Aim: Stroke is the second most common cause of mortality and disability worldwide with ischemic strokes being the predominant type. The advent of neuroprotectants brought hope of improved outcomes and quality of life, but current guidelines, despite numerous trials, have no strong recommendation adv...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Shafiq Dexter B. Abou Zaki, Johnny K. Lokin
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Open Exploration Publishing Inc. 2023-10-01
Schriftenreihe:	Exploration of Neuroprotective Therapy
Schlagworte:	ischemic stroke neuroprotectants cdp-choline cerebrolysin edaravone mlc601
Online-Zugang:	https://www.explorationpub.com/Journals/ent/Article/100457
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!